**Abstract**

The hypothalamus is well known to control feeding behavior. Since opioid receptors are reported to exist in the hypothalamus, we investigated whether μ-, δ- and κ-opioid receptors in the lateral hypothalamus (LH), the hunger center, regulate feeding behavior. Non-selective (naloxone; 3 mg/kg, s.c.), selective μ- (β-funaltrexamine, β-FNA; 10 mg/kg, s.c.), δ- (naltrindole; 3 mg/kg, s.c.) and κ- (norbinaltorphimine, norBNI; 20 mg/kg, s.c.) opioid receptor antagonists significantly decreased food intake. Using immunohistochemistry, we showed that μ-, δ- and κ-opioid receptors were present in the LH. The injection of naloxone (20 μg/side) into the LH significantly decreased food intake whereas the injection of naloxone (20 μg/side) outside of the LH did not affect food intake. The injection of β-FNA (2 μg/side), naltrindole (1 μg/side) or norBNI (2 μg/side) into the LH also significantly decreased food intake. Furthermore, all of these antagonists significantly decreased the mRNA level of preproorexin, which is a precursor of orexin, but not those of other hypothalamic neuropeptides. In addition, the injection of the GABA~A~ receptor agonist muscimol (5 μg/side) into the LH significantly decreased food intake, which was inhibited by the GABA~A~ receptor antagonist bicuculline (50 μg/side). Muscimol (1 mg/kg, i.p.) decreased the mRNA level of preproorexin in the hypothalamus. Naloxone (3 mg/kg, s.c.) significantly increased the GABA level in the LH and both bicuculline and the GABA release inhibitor 3-mercaptopropionic acid (3-MP, 5 μg/side) attenuated the inhibitory effect of naloxone on feeding behavior. 3-MP also attenuated the effects of β-FNA and norBNI, but not that of naltrindole. These results demonstrated that opioid systems in the LH regulate feeding behavior through orexin neurons. Moreover, μ- and κ-, but not δ-, opioid receptor antagonists inhibit feeding behavior by activating GABA neurons in the LH.
